BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18704021)

  • 1. Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology.
    Wise DD; Felker A; Stahl SM
    CNS Spectr; 2008 Aug; 13(8):647-62. PubMed ID: 18704021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special issues related to the treatment of depression in women.
    Yonkers KA
    J Clin Psychiatry; 2003; 64 Suppl 18():8-13. PubMed ID: 14700449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.
    Soares CN
    Drugs Aging; 2013 Sep; 30(9):677-85. PubMed ID: 23801148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression.
    Archer JS
    Menopause; 1999; 6(1):71-8. PubMed ID: 10100184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogen in the treatment of depression.
    Grigoriadis S; Kennedy SH
    Am J Ther; 2002; 9(6):503-9. PubMed ID: 12424508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.
    Soares CN; Poitras JR; Prouty J
    Drugs Aging; 2003; 20(2):85-100. PubMed ID: 12534310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of depression throughout the female life cycle.
    Burt VK; Stein K
    J Clin Psychiatry; 2002; 63 Suppl 7():9-15. PubMed ID: 11995779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders.
    Borrow AP; Cameron NM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():13-25. PubMed ID: 24865152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 4():15-24. PubMed ID: 9554317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-related mood disorders: reproductive life cycle factors.
    Douma SL; Husband C; O'Donnell ME; Barwin BN; Woodend AK
    ANS Adv Nurs Sci; 2005; 28(4):364-75. PubMed ID: 16292022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment.
    Burt VK; Altshuler LL; Rasgon N
    Harv Rev Psychiatry; 1998; 6(3):121-32. PubMed ID: 10372280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of perimenopausal depression.
    Parry BL
    Int J Womens Health; 2010 Aug; 2():143-51. PubMed ID: 21072307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of hormones and menopausal status with depressed mood in women with no history of depression.
    Freeman EW; Sammel MD; Lin H; Nelson DB
    Arch Gen Psychiatry; 2006 Apr; 63(4):375-82. PubMed ID: 16585466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of exogenous estrogen on depressive mood in women: A systematic review and meta-analysis of randomized controlled trials.
    Zhang J; Yin J; Song X; Lai S; Zhong S; Jia Y
    J Psychiatr Res; 2023 Jun; 162():21-29. PubMed ID: 37068417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A guide to the treatment of depression in women by estrogens.
    Studd JW
    Climacteric; 2011 Dec; 14(6):637-42. PubMed ID: 21878053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitors.
    Delini-Stula A
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):121-33. PubMed ID: 2431464
    [No Abstract]   [Full Text] [Related]  

  • 18. Using positron emission tomography to investigate hormone-mediated neurochemical changes across the female lifespan: implications for depression.
    Zsido RG; Villringer A; Sacher J
    Int Rev Psychiatry; 2017 Dec; 29(6):580-596. PubMed ID: 29199875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.
    Toffol E; Heikinheimo O; Partonen T
    Menopause; 2015 May; 22(5):564-78. PubMed ID: 25203891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary research on multi-neurotransmitters' change regulation in 120 depression patients' brains].
    Chi M; Qing XM; Pan YS; Xu FQ; Liu C; Zhang C; Xu ZH
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1516-24. PubMed ID: 25039193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.